27851974|t|eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data
27851974|a|Epigenome-wide association studies (EWAS) provide an alternative approach for studying human disease through consideration of non-genetic variants such as altered DNA methylation. To advance the complex interpretation of EWAS, we developed eFORGE (http://eforge.cs.ucl.ac.uk/), a new standalone and web-based tool for the analysis and interpretation of EWAS data. eFORGE determines the cell type - specific regulatory component of a set of EWAS -identified differentially methylated positions. This is achieved by detecting enrichment of overlap with DNase I hypersensitive sites across 454 samples (tissues, primary cell types, and cell lines) from the ENCODE, Roadmap Epigenomics, and BLUEPRINT projects. Application of eFORGE to 20 publicly available EWAS datasets identified disease - relevant cell types for several common diseases, a stem cell -like signature in cancer, and demonstrated the ability to detect cell - composition effects for EWAS performed on heterogeneous tissues. Our approach bridges the gap between large-scale epigenomics data and EWAS - derived target selection to yield insight into disease etiology.
27851974	0	6	eFORGE	T073,T170	C0037585
27851974	10	14	Tool	T073,T170	C0037585
27851974	31	56	Cell Type-Specific Signal	T043	C0037083
27851974	60	70	Epigenomic	T091	C2936263
27851974	71	75	Data	T078	C1511726
27851974	76	110	Epigenome-wide association studies	T063	C2350277
27851974	112	116	EWAS	T063	C2350277
27851974	154	162	studying	T062	C0008972
27851974	163	168	human	T016	C0086418
27851974	169	176	disease	T047	C0012634
27851974	202	222	non-genetic variants	T080	C0205419
27851974	239	254	DNA methylation	T044	C0376452
27851974	297	301	EWAS	T063	C2350277
27851974	316	322	eFORGE	T073,T170	C0037585
27851974	375	389	web-based tool	T073,T170	C0037585
27851974	398	406	analysis	T169	C1524024
27851974	429	433	EWAS	T063	C2350277
27851974	434	438	data	T078	C1511726
27851974	440	446	eFORGE	T073,T170	C0037585
27851974	462	471	cell type	T170	C0449475
27851974	474	482	specific	T080	C0205369
27851974	483	493	regulatory	T077	C1704735
27851974	494	503	component	T167	C0729650
27851974	516	520	EWAS	T063	C2350277
27851974	533	547	differentially	T080	C0443199
27851974	548	558	methylated	T044	C0376452
27851974	559	568	positions	T082	C0733755
27851974	590	599	detecting	T033	C0442726
27851974	614	621	overlap	T052	C2700387
27851974	627	634	DNase I	T116,T126	C0011519
27851974	635	655	hypersensitive sites	T086	C0004793
27851974	667	674	samples	T077	C2347026
27851974	676	683	tissues	T024	C0040300
27851974	685	692	primary	T080	C0205225
27851974	693	703	cell types	T170	C0449475
27851974	709	719	cell lines	T025	C0007600
27851974	730	736	ENCODE	T170	C0282574
27851974	738	757	Roadmap Epigenomics	T170	C0282574
27851974	763	781	BLUEPRINT projects	T170	C0282574
27851974	798	804	eFORGE	T073,T170	C0037585
27851974	830	834	EWAS	T063	C2350277
27851974	835	843	datasets	T170	C0150098
27851974	855	862	disease	T047	C0012634
27851974	865	873	relevant	T080	C2347946
27851974	874	884	cell types	T170	C0449475
27851974	897	903	common	T081	C0205214
27851974	904	912	diseases	T047	C0012634
27851974	916	925	stem cell	T025	C0038250
27851974	945	951	cancer	T191	C0006826
27851974	985	991	detect	T033	C0442726
27851974	992	996	cell	T025	C0007634
27851974	999	1010	composition	T201	C0486616
27851974	1011	1018	effects	T080	C1280500
27851974	1023	1027	EWAS	T063	C2350277
27851974	1041	1062	heterogeneous tissues	T024	C1179404
27851974	1113	1124	epigenomics	T091	C2936263
27851974	1125	1129	data	T078	C1511726
27851974	1134	1138	EWAS	T063	C2350277
27851974	1141	1148	derived	T080	C1441547
27851974	1149	1155	target	T169	C1521840
27851974	1156	1165	selection	T052	C1707391
27851974	1188	1204	disease etiology	T169	C1314792